Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Global Medical REIT (GMRE-PB) Capital Expenditures (2016 - 2025)

Global Medical REIT (GMRE-PB) has disclosed Capital Expenditures for 12 consecutive years, with $48000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures fell 99.94% year-over-year to $48000.0, compared with a TTM value of $70.5 million through Dec 2025, down 13.66%, and an annual FY2025 reading of $70.5 million, down 13.66% over the prior year.
  • Capital Expenditures was $48000.0 for Q4 2025 at Global Medical REIT, down from $68.7 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $148.9 million in Q3 2022 and bottomed at -$164.5 million in Q4 2021.
  • Average Capital Expenditures over 5 years is $16.1 million, with a median of $1.5 million recorded in 2023.
  • The sharpest move saw Capital Expenditures plummeted 175.92% in 2021, then soared 13730.75% in 2025.
  • Year by year, Capital Expenditures stood at -$164.5 million in 2021, then surged by 100.2% to $335000.0 in 2022, then skyrocketed by 352.84% to $1.5 million in 2023, then soared by 5154.98% to $79.7 million in 2024, then plummeted by 99.94% to $48000.0 in 2025.
  • Business Quant data shows Capital Expenditures for GMRE-PB at $48000.0 in Q4 2025, $68.7 million in Q2 2025, and $1.8 million in Q1 2025.